Multiple Sclerosis Clinical Trials in Bethesda, Maryland

10 recruitingBethesda, Maryland

Showing 110 of 10 trials

Recruiting
Phase 1Phase 2

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)250 enrolled1 locationNCT03109288
Recruiting

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS)3,750 enrolled1 locationNCT00001248
Recruiting

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Multiple SclerosisCentral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID)2,400 enrolled1 locationNCT00794352
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 1

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

Multiple SclerosisProgressive Multifocal LeukoencephalopathyOther Neuroinflammatory Diseases With BBB Leakage
National Institute of Neurological Disorders and Stroke (NINDS)15 enrolled1 locationNCT05849467
Recruiting
Phase 2

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS)30 enrolled1 locationNCT02784210
Recruiting

Pathological Basis of MRI Signal Changes in Multiple Sclerosis

Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS)250 enrolled1 locationNCT02659956
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Secondary-progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals1,275 enrolled208 locationsNCT07225504
Recruiting

Genes and Environment in Multiple Sclerosis

Multiple Sclerosis
Columbia University5,000 enrolled5 locationsNCT01353547
Recruiting

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

Multiple Sclerosis
Bristol-Myers Squibb1,182 enrolled3 locationsNCT05170126